Oventus Medical Ltd (ASX: OVN) is pleased to announce the launch of the O2Vent® Optima device in Australia, an important addition to the Company’s sleep treatment platform. The O2Vent® Optima is the newest product in the O2Vent® oral device range. It offers a new treatment alternative for the potentially fatal condition, obstructive sleep apnoea (OSA).
For more information, download the attached PDF.
Download this document
